Litcius/Paper detail

Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials

Jacques Donnez, Hugh S. Taylor, Elizabeth A. Stewart, Linda Bradley, Erica E. Marsh, David F. Archer, Ayman Al‐Hendy, Felice Petraglia, Nelson B. Watts, Jean‐Pierre Gotteland, Elke Bestel, Paul Terrill, Ernest Loumaye, Andrew Humberstone, Elizabeth Garner

2022The Lancet73 citationsDOI

Topics & Concepts

Norethisterone acetateMedicinePlaceboNorethisteroneUterine fibroidsUlipristal acetateClinical endpointInternal medicineProgestinUrologyHormoneGynecologyGastroenterologyEndocrinologyRandomized controlled trialPopulationFamily planningPathologyEnvironmental healthResearch methodologyAlternative medicineUterine Myomas and TreatmentsEndometriosis Research and TreatmentGynecological conditions and treatments